Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0271991 CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described...
2018/0271990 PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents....
2018/0271989 PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents....
2018/0271988 PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that are useful for delivering therapeutic, diagnostic and imaging agents....
2018/0271986 GLYCOTARGETING THERAPEUTICS
Several embodiments of the present disclosure relate to therapeutic compositions configured to target the liver of a subject and that are useful in the...
2018/0271985 Neurotherapeutic Nanoparticle Compositions Comprising Leukemia Inhibitory Factor
There are provided compositions and methods for treatment of neurodegeneative diseases and CNS injury. The compositions a pharmaceutically acceptable carrier...
2018/0271984 POLYLACTIDE COMPOSITIONS AND USES THEREOF
The present invention provides compositions and methods relating to polylactides which may be used for drug delivery (e.g., parenteral delivery), wherein an...
2018/0271983 TRANSDERMAL CARRIER
Improved formulations for topical treatment that ensure at least localized transdermal or systemic delivery of an active agent through skin, nails or hair...
2018/0271982 LIQUID PRODUCTS HAVING INCREASED SOLIDS CONCENTRATIONS
The present invention discloses liquid compositions that include an active compound, water, and means for inhibiting crystal formation or precipitation of the...
2018/0271981 PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These...
2018/0271980 DRUG DEVICE CONFIGURED FOR WIRELESS COMMUNICATION
This invention relates to an ingestible drug delivery device configured for wireless communication with other ingestible drug delivery devices.
2018/0271979 TRANS CAROTENOIDS, THEIR SYNTHESIS, FORMULATION AND USES
The invention relates to trans carotenoid compounds and salts thereof as well as compositions thereof, methods for making them, and uses thereof. These...
2018/0271978 BIOMATERIALS FOR COMBINED RADIOTHERAPY AND IMMUNOTHERAPY OF CANCER
Compositions and methods for the radiological and immunotherapeutic treatment of cancer are provided. Metallic nanoparticles conjugated with an immunoadjuvant...
2018/0271977 METHODS RELATED TO TIM 3, A TH1-SPECIFIC CELL SURFACE MOLECULE, FOR ACTIVATING ANTIGEN PRESENTING CELLS
The present invention provides compositions and methods useful for promoting or reducing T-cell trafficking to a target tissue. Also provided are compositions...
2018/0271976 METHODS FOR GENERATING NEUTRALIZING ANTI-PATHOGEN ANTIBODIES BY DIRECTING THE HUMORAL RESPONSE TOWARD DESIRED...
Methods for generating antibodies to immuno-subdominant epitopes of elusive pathogens and vaccines and methods of vaccinating subjects against elusive...
2018/0271975 HUMAN CYTOMEGALOVIRUS RNA VACCINES
The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
2018/0271974 HERPES SIMPLEX VIRUS TYPE-1(HSV-1) VACCINE STRAIN VC2 GENERATING AN ANTI-EHV-1 IMMUNE RESPONSE
The disclosure encompasses recombinant nucleic acids comprising a nucleotide sequence encoding a live-attenuated chimeric Herpes Simplex Virus Type-1 (HSV-1)...
2018/0271973 COMPOSITIONS COMPRISING CH505 ENVELOPES, AND TRIMERS (EIGHT VALENT HIV-1 COMPOSITION AND METHODS)
In certain aspects the invention provides a selection of HIV-1 envelopes suitable for use as immunogens, and methods of using these immunogens in vaccination...
2018/0271972 DESIGN AND CHARACTERIZATION OF INFLUENZA VACCINES
Provided herein are optimized, recombinant influenza HA polypeptides that elicit immune responses. Also provided are compositions and kits comprising the...
2018/0271971 ANTIGENS AND VACCINES DIRECTED AGAINST HUMAN ENTEROVIRUSES
The instant invention provides materials and methods for producing immunologically active antigens derived from members of the Picornaviridae virus family. The...
2018/0271970 RESPIRATORY SYNCYTIAL VIRUS VACCINE
The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions...
2018/0271969 STREPTOCOCCUS SUIS POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION
The present invention relates to an immunogenic composition comprising polysaccharide-protein conjugates wherein each conjugate contains a capsular...
2018/0271968 Conjunctivitis Vaccines
Compositions comprising antigenic peptides, and their use in inducing an immunoprotective response in a subject against an infection with Streptococcus...
2018/0271967 OUTER MEMBRANE VESICLES AND USES THEREOF
The disclosure relates to outer membrane vesicles from Francisella and Piscirickettsia, and their use in vaccine compositions. In particular, the present...
2018/0271966 Live Attenuated Heterologous Vaccine for Leptospira
The present invention provides compositions or vaccines that contain a recombinant or an attenuated Leptospira interrogans that elicit an immune response in...
2018/0271965 UTILIZATION OF RECOMBINANT INFLUENZA VIRUSES AND MODIFIED VACCINIA ANKARA VIRUS (MVA) WITH GENES THAT ENCODE...
The present invention concerns to recombinant influenza viruses and modified Vaccinia Ankara viruses (MVA), and to a process for construction of recombinant...
2018/0271964 NUCLEIC ACID COMPRISING OR CODING FOR A HISTONE STEM-LOOP AND A POLY(A) SEQUENCE OR A POLYADENYLATION SIGNAL...
The present invention relates to a nucleic acid sequence, comprising or coding for a coding region, encoding at least one peptide or protein comprising a...
2018/0271963 CANCER VACCINE FOR CATS
The present invention provides an immunogenic composition comprising a nucleic acid that comprises a sequence encoding a cat telomerase deprived of telomerase...
2018/0271962 Peptide Conjugated Particles
The present invention provides compositions comprising peptide-coupled biodegradable poly(lactide-co-glycolide) (PLG) particles. In particular, PLG particles...
2018/0271961 METHODS FOR INDUCING SELECTIVE APOPTOSIS
Provided herein are methods for cell therapy by modifying transfused cells to express an inducible caspase 9 protein, so that the cells may be selectively...
2018/0271960 METHOD TO TREAT CANCER USING ARGININE DELPETOR AND ORNITHINE DECARBOXYLASE (ODC) INHIBITOR
One example embodiment is a method of treating lung carcinoma in a subject in need thereof. The method includes administering to the subject a therapeutically...
2018/0271959 SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS
A thermo-reversible thermoplastic pharmaceutical composition, comprising a botulinum toxin and a biocompatible poloxamer which provides thermoreversibility to...
2018/0271958 COMPOSITIONS AND METHODS FOR TREATMENT OF OCULAR DISEASES
Use of activated protein C (APC) for treatment and prevention of ocular diseases, disorders or conditions associated with retinal leakage and CNV such as...
2018/0271957 METHODS TO TREAT CEROID LIPOFUSCINOSIS USING A RECOMBINANT ADENO-ASSOCIATED VIRUS
A method to prevent, inhibit or treat one or more symptoms associated with a disease of the central nervous system by intrathecally, intracerebroventricularly...
2018/0271956 METHODS TO TREAT POMPE DISEASE USING A RECOMBINANT ADENO-ASSOCIATED VIRUS
A method to prevent, inhibit or treat one or more symptoms associated with a disease of the central nervous system by intrathecally, intracerebroventricularly...
2018/0271955 ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM
A method to prevent, inhibit or treat one or more symptoms associated with a disease of the central nervous system by intrathecally, intracerebroventricularly...
2018/0271954 TREATING CANCER WITH CAS ENDONUCLEASE COMPLEXES
The invention generally relates to compositions and methods for targeted delivery of a Cas endonuclease or nucleic acid encoding a Cas endonuclease to a fusion...
2018/0271953 ANTI-NET COMPOUNDS FOR TREATING AND PREVENTING FIBROSIS AND FOR FACILITATING WOUND HEALING
Embodiments of the technology described herein are based, in part, upon the discovery that NETosis, the formation of neutrophil extracellular traps (NETs) is...
2018/0271952 Combination of Bactericidal Agent With a Lysosomotropic Alkalinising Agent for the Treatment of a Bacterial...
The present invention relates to the field of medicine, specifically the field of bacterial infection and treatment thereof.
2018/0271951 METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY
The present invention relates in part to nucleic acids, including nucleic acids encoding proteins, therapeutics and cosmetics comprising nucleic acids, methods...
2018/0271950 USE OF FULL-LENGTH AMELOGENIN FOR PROMOTING NERVE GROWTH OR REGENERATION
A method of promoting nerve growth or regeneration in a subject in need thereof, wherein the subject is not afflicted with a substantial connective tissue...
2018/0271949 THERAPEUTIC TREATMENT FOR NEUROTROPHIC KERATOPATHY
The invention provides reagents, pharmaceutical compositions and methods for the treatment of prevention of disorders and diseases related to defects in...
2018/0271948 Methods for Producing Stable Therapeutic Glucagon Formulations in Aprotic Polar Solvents
Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic...
2018/0271947 COAGONISTS OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AND NEUROPEPTIDE Y2 RECEPTOR
Peptide sequences that can serve as agonists of both the glucagon-like peptide 1 receptor (GLP-IR) and the neuropeptide Y2 receptor (NPYR2). The peptide...
2018/0271946 SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS CARRIERS
The disclosure provides one-component, injectable, sustained release formulations which comprise microspheres containing active pharmaceutical ingredients...
2018/0271945 UROCORTIN 2 ANALOGS AND USES THEREOF
Disclosed are polypeptides that are analogs of urocortin 2 that have pharmacological activity similar to urocortin 2 but have improved water solubility...
2018/0271944 METHODS FOR TREATING DISEASES MEDIATED BY ERBB4-POSITIVE PRO-INFLAMMATORY MACROPHAGES
Provided herein are methods and compositions for treating disease-states associated with presence of increased number of ErbB4+ pro-inflammatory macrophages in...
2018/0271943 METHODS FOR TREATING INFLAMMATION WITH TGF-BETA
Provided wherein are methods for treating inflammation. In one embodiment, the method includes administering an effective amount of a composition to a subject...
2018/0271942 Use of the Insulin-Like-Growth Factor 1 Splice Variant MGF for the Prevention of Myocardial Damage
The invention relates to the use of a Mechano Growth Factor (MGF) polypeptide or a polynucleotide encoding an MGF polypeptide in the manufacture of a...
2018/0271941 METHODS FOR MODULATING DEVELOPMENT AND FUNCTION OF PHOTORECEPTOR CELLS
The present invention relates to compositions and methods comprising administering gene modifiers for treating ocular disease.
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.